REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Amarox Pharma Global (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Amarox Pharma Global Profile Updated: November 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT Amarox Pharma Global is an enterprise in Indonesia, with the main office in Tasikmalaya. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on March 24, 2017. The latest financial highlights indicate a net sales revenue increase of 4.1% in 2023. There was a total growth of 4.51% in PT Amarox Pharma Global’s total assets over the same period.

Headquarters
Delta Silicon II Industrial Park Blok F 18, No.2B
Tasikmalaya; West Java; Postal Code: 17532

Contact Details: Purchase the PT Amarox Pharma Global report to view the information.

Website: http://hetero.com

Basic Information
Outstanding Shares:
Purchase the PT Amarox Pharma Global report to view the information.
Registered Capital:
Purchase the PT Amarox Pharma Global report to view the information.
Incorporation Date:
March 24, 2017
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Amarox Pharma Global report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
4.1%
Total operating revenue
4.1%
Total assets
4.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?